These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2979254)

  • 1. Enprostil inhibits post-prandial gastrin release: a dose-response study.
    Lanzon-Miller S; Allison MC; Pounder RE; Ball S; Hamilton MR; Chronos NA
    Aliment Pharmacol Ther; 1988 Aug; 2(4):317-23. PubMed ID: 2979254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of the gastric acid and serum gastrin-lowering effects of the prostaglandin E2 analog enprostil.
    Baak LC; Jansen JB; Meijer JL; Lamers CB
    Clin Pharmacol Ther; 1993 Jun; 53(6):668-4. PubMed ID: 8513659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory action of enprostil (4,5-dehydro-16-phenoxy-17,18,19,20-tetranor-PGE2) on tetra-gastrin stimulated acid secretion in human subjects.
    Moriga M; Aono M; Narusawa H; Kohli Y; Kato T; Kajiyama G; Inoue M; Miyoshi A
    Gastroenterol Jpn; 1989 Apr; 24(2):115-9. PubMed ID: 2501133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of enprostil on gastric emptying, intestinal transit time and post-prandial release of gastro-intestinal peptides.
    Nicholl CG; Carolan G; Sevelius H; Bloom SR
    Digestion; 1989; 43(1-2):47-55. PubMed ID: 2509267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a single oral dose of enprostil on gastric secretion and gastrin release. Studies in healthy volunteers and patients with pernicious anemia.
    Buchanan N; Laferla G; Hearns J; Buchanan KD; Crean GP; McColl KE
    Am J Med; 1986 Aug; 81(2A):40-3. PubMed ID: 3092653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of enprostil on basal and meal-stimulated gastric acid and pepsin secretion, serum gastrin and gastric emptying in healthy persons.
    Berstad K; Massey H; Berstad A
    Aliment Pharmacol Ther; 1988 Feb; 2(1):65-72. PubMed ID: 2979235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
    Thomas FJ; Koss MA; Hogan DL; Isenberg JI
    Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of two-week treatment with enprostil (35 micrograms twice a day) on 24-hour serum gastrin levels.
    Florent C; Cogoni C; Joubert M; Desaint B
    Dig Dis Sci; 1990 Nov; 35(11):1352-7. PubMed ID: 2121423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the E2 prostaglandin enprostil, and the somatostatin analogue SMS 201 995, on the growth of a human gastric cell line, MKN45G.
    Watson SA; Durrant LG; Morris DL
    Int J Cancer; 1990 Jan; 45(1):90-4. PubMed ID: 2105279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisecretory and serum gastrin lowering effect of enprostil in patients with duodenal ulcer disease.
    Mahachai V; Walker K; Sevelius H; Thomson AB
    Gastroenterology; 1985 Sep; 89(3):555-61. PubMed ID: 3926591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of synthetic prostaglandin E2 analog enprostil on omeprazole-induced hypergastrinemia and hyperpepsinogenemia.
    Meijer JL; Crobach LF; Jansen JB; Lamers CB
    Dig Dis Sci; 1994 Mar; 39(3):609-16. PubMed ID: 8131700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prostaglandins on gastrin release from canine antral mucosal cells in primary culture.
    Schepp W; Chan CB; Giraud AS; Avedian D; Chen MC; Chew P; Walsh JH; Soll AH
    Am J Physiol; 1994 Feb; 266(2 Pt 1):G194-200. PubMed ID: 8141291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic interaction between an H2-receptor antagonist and enprostil on 24-hour intragastric pH, serum gastrin concentration, and tissue immunoperoxidase staining for gastrin, somatostatin, and serotonin in a patient with metastatic gastrinoma.
    Sherbaniuk R; Jewell LD; Yacoub W; Pinchbeck B; Salkie ML; Walker K; Mahachai V; Kirdeikis P; Zuk L; Brunet MK
    Clin Ther; 1986; 8(6):667-88. PubMed ID: 2878726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of enprostil on duodeno-jejunal motility in man.
    Ducrotte P; Parent B; Masliah C; Joubert M; Colin R; Denis P
    Aliment Pharmacol Ther; 1990 Feb; 4(1):73-81. PubMed ID: 2129489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of enprostil on glucose and lipid metabolism in type 2 diabetes.
    Davis TM; Proby C; Strong JA; Thompson GR; Massey H; Scott R; Bloom SR
    Diabet Med; 1989 Jul; 6(5):400-5. PubMed ID: 2527675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enprostil reduces G-cell hyperplasia and hypergastrinemia in duodenal ulcer.
    Jewell LD; Yacoub W; Salkie ML; Sherbaniuk R; Walker K; Mahachai V; Kirdeikis P; Simpson I; Zuk L; Brunet MK
    Clin Ther; 1987; 9(3):281-95. PubMed ID: 3111703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of proglumide and enprostil on omeprazole-induced fundic endocrine cell hyperplasia in rats.
    Delwaide J; Latour P; Gast P; Louis E; Belaïche J
    Gastroenterol Clin Biol; 1993; 17(11):792-6. PubMed ID: 8143943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of gastrin and enprostil, a PGE2 analog, on colonic cancerous cell growth].
    Yactayo S; Patrice T; Foultier MT; Berrada A; Xu XN
    Gastroenterol Clin Biol; 1991; 15(6-7):519-24. PubMed ID: 1916130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variations of plasma gastrin (basal and postprandial) in ththtreatmentof duodenal ulcer with either enprostil or ranitidine. Correlations with rates of relapse].
    Bado A; Corrion F; Bernades P; Chevalier T; Galmiche JP; Laverdant C; Mignon M; Minaire Y; Pariente A; Vicari F
    Gastroenterol Clin Biol; 1994; 18(6-7):623-9. PubMed ID: 7875420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of serum lipoproteins in man by the oral administration of a prostaglandin analogue (enprostil).
    Schwartz KE; Zaro B; Burton P; Hunt J; Pennelly L; Sevelius H
    Atherosclerosis; 1988 May; 71(1):9-16. PubMed ID: 3132181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.